# Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
Canonical URL: https://biopharmsignal.com/news/RPTX/repare-therapeutics-provides-business-update-and-reports-second-quarter-2025-financial-results
Ticker: RPTX
Company: Repare Therapeutics
Source: Repare Therapeutics
Published: 2025-08-08 11:00 EST
Original Source URL: https://ir.reparerx.com
## Summary

Entered into worldwide licensing agreement with Debiopharm for lunresertib Evaluating strategic alternatives to maximize shareholder value Initial data for LIONS and POLAR trials expected to be reported in Q4 2025 $109.5 million in cash and cash equivalents and marketable securities CAMBRIDGE,

## Article Body
Entered into worldwide licensing agreement with Debiopharm for lunresertib Evaluating strategic alternatives to maximize shareholder value Initial data for LIONS and POLAR trials expected to be reported in Q4 2025 $109.5 million in cash and cash equivalents and marketable securities CAMBRIDGE,
## Recent Company News
- 2026-01-16 21:58 EST — [Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.](https://biopharmsignal.com/news/RPTX/repare-shareholders-approve-acquisition-by-xenotherapeutics-inc) — Source: Repare Therapeutics
- 2025-12-24 12:00 EST — [Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration](https://biopharmsignal.com/news/RPTX/repare-therapeutics-announces-acquisition-of-pol-atpase-inhibitor-rp-3467-by-gilead-sciences-for-up-to-30-million-in-total-consideration) — Source: Repare Therapeutics
- 2025-11-20 22:25 EST — [Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.](https://biopharmsignal.com/news/RPTX/repare-therapeutics-enters-into-support-and-voting-agreements-with-significant-shareholders-for-proposed-transaction-with-xenotherapeutics-inc) — Source: Repare Therapeutics
- 2025-11-14 21:44 EST — [Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.](https://biopharmsignal.com/news/RPTX/repare-therapeutics-enters-into-definitive-agreement-to-be-acquired-by-xenotherapeutics-inc) — Source: Repare Therapeutics
- 2025-10-13 20:05 EST — [Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics](https://biopharmsignal.com/news/RPTX/repare-therapeutics-to-present-initial-data-from-phase-1-lions-clinical-trial-at-37th-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics) — Source: Repare Therapeutics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)